Our economic analysis of patient-level data from PROGNOSIS Asia shows that implementation of the sFlt-1/PlGF ratio as a diagnostic aid in current standard-of-care procedures could reduce the hospitalization rate for Japanese women with suspected preeclampsia from 14.4 to 8.7%. This evidence concerns the gene PGF and preeclampsia.